[AIDS 2026] Africa Health Research Institute: Mobile Men study: injectable PrEP beats pills for men who travel for work
![[AIDS 2026] Africa Health Research Institute: Mobile Men study: injectable PrEP beats pills for men who travel for work](/api/imagekit?u=https%3A%2F%2Fwww.eatg.org%2Fwp-content%2Fuploads%2F2023%2F12%2F1674900.jpg&w=3840&q=75)
Results from the Mobile Men study presented at AIDS 2026 show that long-acting injectable PrEP is more effective than oral pills for men who travel frequently for work. The study highlights the feasibility of mobile clinics in providing HIV prevention services to mobile populations in Uganda and South Africa.
Why it matters
Improving access to and adherence for HIV prevention among high-risk, mobile populations is critical for global efforts to control the spread of the virus.
The first results from the Mobile Men study, presented at AIDS 2026, show that long-acting injectable cabotegravir helped men who travel for work stay on HIV prevention for longer than oral PrEP. The study also found that same-day HIV testing and starting injectable PrEP was feasible. For those taking oral PrEP, the study found that event-based PrEP (alone or combined with daily) was preferred to daily-only dosing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in